Respiratory

Respiratory

Respiratory

Boehringer Ingelheim
has over 90 years
of heritage
in managing
respiratory diseases
Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life
 

 

Early intervention to optimize lung function

Document ID: PC-TH-100464

01/06/2019

Author: Boehringer Ingelheim


The greatest decline in lung function is in GOLD stage 2.1 This lung function decline in early stages is also linked to a dramatic reduction in activities and can potentially lead to a downward spiral. Hence it is vital for patients to receive optimum treatment in the early stages of disease.2,3

Related content

 
PC-TH-100292
Production date: Jun 2019